Optic Neuritis & Demyelinating Disease

Optic neuritis (ON) is acute inflammatory demyelination of the optic nerve and the single most exam-relevant link between Ophthalmology and Neurology. The classic teaching is painful monocular visual loss with a relative afferent pupillary defect (RAPD), dyschromatopsia, and a central scotoma — and in the retrobulbar variant, a normal-looking disc, hence "the patient sees nothing and the doctor sees nothing."

Definition & Classification

Optic neuritis is inflammation/demyelination of the optic nerve producing acute or subacute loss of vision, usually unilateral and usually in young adults (peak 20–45 years, female predominance ~3:1). It is the presenting feature of multiple sclerosis (MS) in roughly 20–25% of patients.

Anatomical classification:

Type	Site of inflammation	Disc appearance	Pain	Classic association
Retrobulbar neuritis	Optic nerve behind globe	Normal disc (commonest in adults, MS)	Yes, on eye movement	Multiple sclerosis
Papillitis	Optic nerve head	Swollen disc + hyperaemia	Variable	Children, post-viral, syphilis
Neuroretinitis	Disc + peripapillary retina	Disc oedema + macular star	Less	Bartonella (cat-scratch), Lyme, syphilis — NOT MS

High-yield: Retrobulbar neuritis = "patient sees nothing, doctor sees nothing" because the disc is normal in two-thirds of typical demyelinating ON. A swollen disc favours papillitis/neuroretinitis or anterior optic neuropathy.

Aetiological classification:

• Demyelinating — MS-associated (typical/idiopathic) — most common.
• Inflammatory/antibody-mediated — Neuromyelitis optica spectrum disorder (NMOSD, anti-AQP4) and MOG antibody-associated disease (MOGAD).
• Infective — syphilis, Lyme, Bartonella, viral, TB, herpes zoster.
• Para-infectious/post-vaccination — often bilateral, in children.
• Granulomatous — sarcoidosis.

Etiology & Pathophysiology

In demyelinating ON, an autoimmune T-cell–mediated attack strips myelin from optic nerve axons. Demyelination slows or blocks saltatory conduction → reduced visual acuity, impaired colour vision, and a delayed visual evoked potential (VEP). Inflammatory oedema within the tight optic nerve sheath produces the pain on eye movement (the nerve is tethered at the orbital apex and moves with the extraocular muscles).

Uhthoff's phenomenon — transient worsening of vision (blurring/dimming) with a rise in body temperature (exercise, hot bath, fever). The conduction in a partially demyelinated nerve fails as temperature rises. It is a marker of demyelination, not true relapse.

Pulfrich phenomenon — altered depth perception of a swinging pendulum due to asymmetric conduction speed between the two optic nerves.

High-yield: Pain on eye movement + Uhthoff's phenomenon are the two most-tested symptom clues pointing to demyelinating optic neuritis.

Clinical Features

Symptoms:

1. Subacute monocular visual loss evolving over hours to a few days (nadir within 1–2 weeks).
2. Periocular pain worse on eye movement (~90% of cases).
3. Dyschromatopsia — red desaturation; colour vision loss is disproportionately severe relative to acuity.
4. Central or centrocaecal scotoma is the classic field defect (any field defect can occur).
5. Reduced perception of light brightness; photopsias/phosphenes on eye movement.

Signs:

• Relative Afferent Pupillary Defect (RAPD / Marcus Gunn pupil) — the single most important sign; demonstrated by the swinging flashlight test (affected pupil paradoxically dilates when light swings to it). Present in essentially all unilateral cases.
• Reduced visual acuity (range 6/9 to no perception of light).
• Normal fundus in retrobulbar type; disc swelling in papillitis.
• Impaired contrast sensitivity and colour (Ishihara plates fail).
• Optic atrophy (temporal pallor) develops 4–6 weeks later as the disc becomes pale.

High-yield: RAPD will be absent if disease is bilateral and symmetric. A "negative" swinging-flashlight test does not exclude bilateral ON.

Diagnosis & Investigation of Choice

Diagnosis is largely clinical, but investigations confirm and risk-stratify for MS.

Approach (flow):

Acute painful monocular visual loss + RAPD + dyschromatopsia → confirm field defect (central scotoma) → MRI brain + orbits with gadolinium (investigation of choice) → check AQP4 & MOG antibodies if atypical → treat.

Investigation	Finding / Purpose
MRI brain + orbits with contrast	Enhancement of optic nerve; periventricular white-matter (Dawson's finger) lesions predict MS — single most important prognostic test
Visual evoked potential (VEP)	Delayed (prolonged) latency with preserved amplitude — hallmark of demyelination; useful when MRI equivocal
OCT	Retinal nerve fibre layer (RNFL) thinning weeks later; monitors axonal loss
Visual fields (perimetry)	Central/centrocaecal scotoma
AQP4-IgG (anti-aquaporin-4)	Diagnoses NMOSD — alters treatment & prognosis
MOG-IgG	MOGAD — bilateral, steroid-responsive, often relapsing
LP/CSF oligoclonal bands	Supports MS; not routine
VDRL/FTA-ABS, ACE, Bartonella serology	When atypical/infective suspected

High-yield (most-tested): MRI brain is the investigation of choice and the strongest predictor of conversion to MS. VEP shows increased latency with normal/preserved amplitude (demyelination), whereas axonal loss reduces amplitude.

High-yield (ONTT data): With ≥1 white-matter lesion on baseline MRI, the 15-year risk of MS is ~72%; with a normal MRI it is ~25%.

Management & Drug of Choice

Management is defined by the landmark Optic Neuritis Treatment Trial (ONTT) — among the most heavily tested clinical trials in NEET PG.

ONTT regimen — IV methylprednisolone:

• IV methylprednisolone 1 g/day (250 mg QID) for 3 days, followed by oral prednisolone 1 mg/kg/day for 11 days, then a short taper.

Key ONTT conclusions (memorise):

1. IV steroids speed recovery of vision but do NOT change the final visual outcome at 6–12 months.
2. Oral prednisolone ALONE (standard dose) is contraindicated — it increased the rate of recurrent optic neuritis.
3. Most patients recover good vision spontaneously; visual prognosis is generally good even without treatment.
4. MRI lesion burden predicts MS conversion; interferon/disease-modifying therapy is considered in high-risk patients (CHAMPS trial).

High-yield: "Standard-dose oral steroids alone are harmful in optic neuritis" — increases recurrence (ONTT). The accepted regimen is IV methylprednisolone → oral taper.

For NMOSD / MOGAD: acute high-dose IV steroids ± plasma exchange (PLEX) for severe/steroid-refractory loss; long-term immunosuppression (rituximab, eculizumab, azathioprine for NMOSD). Distinguishing these matters because beta-interferons can worsen NMOSD.

Disease-modifying therapy (MS): initiated in high-risk converters (multiple MRI lesions) — interferon-beta, glatiramer, or newer agents.

Complications

• Conversion to multiple sclerosis — the major long-term concern.
• Residual deficits — persistent red desaturation, reduced contrast sensitivity, mild acuity loss in ~10%.
• Optic atrophy — temporal pallor; RNFL thinning on OCT.
• Recurrent optic neuritis — higher in NMOSD/MOGAD and after oral-steroid-only treatment.
• Uhthoff's phenomenon persisting as a chronic nuisance.
• Severe irreversible blindness — more typical of NMOSD than classic MS-ON.

Key Differentials

Feature	Demyelinating ON	NMOSD (AQP4)	NAION	Papilloedema
Age	20–45	Any, often >40	>50, vasculopaths	Any
Laterality	Unilateral	Often bilateral/severe	Unilateral	Bilateral
Pain	Yes (on movement)	Variable	Painless	Headache
Disc	Often normal	Swollen/normal	Swollen, pale + altitudinal	Swollen, hyperaemic
Field defect	Central scotoma	Severe, altitudinal	Altitudinal	Enlarged blind spot
Recovery	Good	Often poor	Poor	Per cause
Key test	MRI + VEP	AQP4-IgG	Disc-at-risk, vascular risk	Raised ICP imaging/LP

Distinguishing pearls:

• NAION (non-arteritic anterior ischaemic optic neuropathy): older, painless, sudden, altitudinal field defect, "disc at risk" (small crowded disc), no RAPD recovery; do NOT give steroids reflexively.
• AION arteritic (GCA): elderly, jaw claudication, raised ESR/CRP — emergency, give high-dose steroids immediately.
• Leber's hereditary optic neuropathy: young men, painless, bilateral sequential, mitochondrial inheritance, central scotoma.
• Toxic/nutritional (B12, methanol, ethambutol): bilateral, painless, centrocaecal scotomas.
• Functional/non-organic visual loss: normal RAPD, normal VEP.

High-yield: Painful + RAPD + central scotoma + young female = optic neuritis. Painless + altitudinal + elderly + disc at risk = NAION.

Mnemonics & Eponyms

• "PAIN-CR" for typical demyelinating ON: Pain on movement, Afferent pupillary defect (RAPD), Impaired colour vision, Normal fundus (retrobulbar), Central scotoma, Recovery good.
• Uhthoff = heat worsens vision. Pulfrich = pendulum/depth illusion. Marcus Gunn = RAPD. Dawson's fingers = periventricular MS plaques. Devic's disease = old name for NMO.
• ONTT mantra: "IV steroids hasten but don't improve; oral-only harms."

Recently asked / exam angle

• Single-best clinical vignette: young woman, painful loss of vision in one eye, normal fundus, RAPD — diagnosis = retrobulbar neuritis and investigation of choice = MRI brain & orbits.
• VEP question: demyelination → prolonged latency, preserved amplitude; axonal loss → reduced amplitude. Frequently a two-statement assertion-reason item.
• ONTT-based item: "Which statement is true?" — answer keys on oral prednisolone alone is contraindicated / increases recurrence and IV steroids speed recovery without changing final acuity.
• Uhthoff's phenomenon definition (vision worsens with heat/exercise) — recurrent one-liner.
• MRI prognosis numbers: white-matter lesions → high MS conversion (~70% at 15 yrs) vs normal MRI (~25%).
• NMOSD vs MS-ON: AQP4-IgG, bilateral/severe, poor recovery, avoid interferon — increasingly asked image/lab integration question.
• Neuroretinitis with macular star → Bartonella (cat-scratch disease), NOT MS — a classic trap distractor.
• Drug-induced optic neuropathy: ethambutol (dose/duration related), linked but distinguished from inflammatory ON.

Rapid revision

1. Optic neuritis = acute demyelinating inflammation of optic nerve; young women, MS link.
2. Triad: painful (on movement) monocular loss + RAPD + dyschromatopsia, with central scotoma.
3. Retrobulbar type = normal disc → "patient sees nothing, doctor sees nothing."
4. RAPD (Marcus Gunn pupil) via swinging flashlight test is the cardinal sign.
5. Investigation of choice = MRI brain + orbits with contrast; predicts MS conversion.
6. VEP = delayed latency, preserved amplitude (demyelination).
7. Uhthoff's = vision worsens with heat/exercise; Pulfrich = depth illusion.
8. Treatment = IV methylprednisolone 1 g/day × 3 days → oral prednisolone taper (ONTT).
9. Oral steroids alone are contraindicated — increase recurrence.
10. IV steroids speed recovery but do not change final visual acuity.
11. Neuroretinitis + macular star = Bartonella, not MS.
12. NMOSD (AQP4-IgG): bilateral, severe, poor recovery — use PLEX/rituximab, avoid interferon.